跳至主要内容
临床试验/CTRI/2025/11/098192
CTRI/2025/11/098192尚未招募不适用

A Randomized Controlled Trial To Evaluate The Efficacy Of Individualized Homoeopathic Treatment In Patients Suffering From Rheumatoid Arthritis.

TANTIA UNIVERSITY1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1

研究概览

简要总结

Rheumatoid Arthritis (RA) is a chronic, autoimmune, and debilitating disease characterized by inflammation, pain, swelling, and eventual destruction of joints. It affects millions of people worldwide, leading to significant morbidity, disability, and decreased quality of life. RA is a complex disorder involving an interplay between genetic, environmental, and immune system factors. The disease process involves the activation of immune cells, release of pro-inflammatory cytokines, and production of autoantibodies, which ultimately lead to joint damage and destruction. The current conventional treatment options for RA include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs),

and biologic agents. However, these treatments have limitations, including side effects, toxicity, and high costs. Moreover, some patients may not respond adequately to these treatments, highlighting the need for alternative therapeutic

approaches. In this context, Homoeopathy, a system of alternative medicine, offers a promising approach to managing RA. Homoeopathic remedies, derived from natural sources, aim to stimulate the body’s self-healing mechanisms and restore balance. Several Homoeopathic remedies have shown potential in reducing inflammation, pain, and improving quality of life in patients with RA. This study aims to investigate the efficacy of Homoeopathic treatment in managing Rheumatoid Arthritis.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • Patients aged 25-60 years with clinically diagnosed and undiagnosed Rheumatoid Arthritis 2 .
  • Gender both Male and Female
  • Both serological positive and negative cases.

排除标准

  • Patients coming with severe comorbidities like CKD , LIVEER DISEASES , HEART DISEASES etc.
  • Pregnant or Lactating individuals.

研究者

发起方
TANTIA UNIVERSITY
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

LAKSHAY MAHAJAN

Sri Ganganagar Homoeopathic Medical College Hospital and Research Institute

研究点 (1)

Loading locations...

相似试验